Comparing biologicals and small molecule drug therapies for chronic respiratory diseases: An EAACI Taskforce on Immunopharmacology position paper-Reference-Cited by-同舟云学术

Comparing biologicals and small molecule drug therapies for chronic respiratory diseases: An EAACI Taskforce on Immunopharmacology position paper

Published:2019-01-08 Issue:3 Volume:74 Page:432-448
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Roth-Walter Franziska¹^ORCID,Adcock Ian M.²^ORCID,Benito-Villalvilla Cristina³,Bianchini Rodolfo¹^ORCID,Bjermer Leif⁴^ORCID,Caramori Gaetano⁵^ORCID,Cari Luigi⁶^ORCID,Chung Kian Fan⁷^ORCID,Diamant Zuzana⁸⁹^ORCID,Eguiluz-Gracia Ibon¹⁰,Knol Edward F.¹¹^ORCID,Kolios Antonios G. A.¹²^ORCID,Levi-Schaffer Francesca¹³^ORCID,Nocentini Giuseppe⁶^ORCID,Palomares Oscar³^ORCID,Puzzovio Pier Giorgio¹³^ORCID,Redegeld Frank A.¹⁴^ORCID,van Esch Betty C. A. M.¹⁴^ORCID,Stellato Cristiana¹⁵^ORCID

Affiliation:

1. Comparative Medicine; The Interuniversity Messerli Research Institute of the University of Veterinary Medicine Vienna; Medical University Vienna and University Vienna; Vienna Austria

2. Molecular Cell Biology Group; National Heart & Lung Institute; Imperial College London; London UK

3. Department of Biochemistry and Molecular Biology; School of Chemistry; Complutense University of Madrid; Madrid Spain

4. Department of Respiratory Medicine and Allergology, Lung and Allergy Research; Allergy, Asthma and COPD Competence center; Lund University; Lund Sweden

5. Pulmonary Unit; Department of Biomedical Sciences; Dentistry, Morphological and Functional Imaging (BIOMORF); University of Messina; Messina Italy

6. Department of Medicine; Section of Pharmacology; University of Perugia; Perugia Italy

7. Experimental Studies Medicine at National Heart & Lung Institute; Imperial College London; Royal Brompton & Harefield NHS Trust; London UK

8. Department of Clinical Pharmacy and Pharmacology; University Medical Center Groningen; University of Groningen; Groningen The Netherlands

9. Department of Respiratory Medicine and Allergology; Institute for Clinical Science; Skane University Hospital; Lund Sweden

10. Allergy Unit and Research Laboratory; Regional University Hospital of Málaga and Biomedical Research Institute of Malaga (IBIMA); Málaga Spain

11. Departments of Immunology and Dermatology/Allergology; University Medical Center Utrecht; Utrecht The Netherlands

12. Department of Immunology; University Hospital Zurich; Zurich Switzerland

13. Institute for Drug Research; School of Pharmacy; Faculty of Medicine; The Hebrew University of Jerusalem; Jerusalem Israel

14. Faculty of Science; Division of Pharmacology; Department of Pharmaceutical Sciences; Utrecht University; Utrecht The Netherlands

15. Department of Medicine, Surgery and Dentistry “Scuola Medica Salernitana”; University of Salerno; Salerno Italy

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/all.13642/fullpdf

Reference97 articles.

1. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015;Collaborators GBDCRD;Lancet Respir Med,2017

2. Global Burden of Disease Collaborative Network Global Burden of Disease Study 2016 (GBD 2016) Results Seattle USIfHMaEI http://ghdx.healthdata.org/gbd-results-tool

3. Global Initiative for Chronic Obstructive Lung Disease Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease 2018

4. Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC);Pearce;Thorax,2007

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemically Administered Anti-uPAR Antibody Plasma and Lung ELF Pharmacokinetics Characterized by Minimal Lung PBPK Model;AAPS PharmSciTech;2023-11-21

2. Relationship between serum iron and blood eosinophil counts in asthmatic adults: data from NHANES 2011-2018;Frontiers in Immunology;2023-09-04

3. Advancing Treatment Strategies: A Comprehensive Review of Drug Delivery Innovations for Chronic Inflammatory Respiratory Diseases;Pharmaceutics;2023-08-17

4. Therapeutic strategies targeting pro-fibrotic macrophages in interstitial lung disease;Biochemical Pharmacology;2023-05

5. New insights into the pathophysiology and therapeutic targets of asthma and comorbid chronic rhinosinusitis with or without nasal polyposis;Clinical Science;2023-05